Keywords: hoechst, propentofylline, set, spring, filing, despite, disappointment

Hoechst's Propentofylline Set For Spring '95 Filing

Article | 03 October 1994

Despite the disappointment of discontinuing development of its dementia treatment velnacrine, after trials involving over 1,000 patients, Hoechst has two further ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Cognex

Tacrine

Adenocard

Adenosine

Arava

Go to drug listing